Author:
DUĞRAL Esra,TURAN Oguzhan Ekrem,BAŞKURT Ahmet Anıl,ÖZCAN Emin Evren
Publisher
Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu
Reference44 articles.
1. 1. Heeringa J, van der Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BHC, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27:949–53
2. 2. Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y., McAnulty, J. H., Zheng, Z., Forouzanfar, M. H., Naghavi, M., Mensah, G. A., Ezzati, M., & Murray, C. J. L. (2014). Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation, 129, 837–847
3. 3. AHA/ACC/HRS Guideline fort he Management of Patients With Atriyal Fibrillation, A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Hearth Rhythm Society 2014
4. 4. Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, et al. Management of patients with atrial fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations). Journal of the American College of Cardiology. 2013; 61(18):1935-44)
5. 5. Gronefeld GC, Lilienthal J, Kuck KH, Hohnloser SH; Pharmacological Intervention in Atrial Fibrillation (PIAF) Study Investigators. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: results from a prospective randomized study. Eur Heart J 2003; 24:1430–1436